Table 2.
RMSE from the exponential model curve fit of on-transient pulmonary V̇o2 kinetics in both heart failure patients and age-matched healthy control subjects
| Healthy Control Subjects |
Heart Failure Patients |
|||
|---|---|---|---|---|
| RMSE | PLB | FNT | PLB | FNT |
| Phase I duration (25 s) | ||||
| Single exponential | 0.040 ± 0.011 | 0.045 ± 0.022 | 0.052 ± 0.014 | 0.050 ± 0.014 |
| Double exponential | 0.045 ± 0.009 | 0.048 ± 0.016 | 0.051 ± 0.015 | 0.048 ± 0.015 |
| Single-exponential phase II pulmonary V̇o2 on-kinetics curve fit | ||||
| Phase I duration, s | ||||
| Model 1 (15 s) | 0.045 ± 0.010 | 0.046 ± 0.021 | 0.054 ± 0.015 | 0.052 ± 0.013 |
| Model 2 (25 s) | 0.040 ± 0.011 | 0.045 ± 0.022 | 0.052 ± 0.014 | 0.051 ± 0.014 |
| Model 3 (35 s) | 0.038 ± 0.012 | 0.042 ± 0.019 | 0.050 ± 0.013 | 0.048 ± 0.013 |
Data are expressed as means ± SD. Phase I durations of 15-s, 25-s, or 35-s length correspond to removal of data from time = 0 to 10, 20, or 30 s, respectively. RMSE, root mean square error; PLB, placebo experimental arm; FNT, fentanyl experimental arm.